Click here for webcast. MENLO PARK, Calif., April 8, 2020 — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that it is working with commercial, academic and government research teams that are investigating SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic. Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. and has now fallen 3 days in a row.During the day the stock fluctuated 10.10% from a day low at $27.14 to a day high of $29.88.The price has fallen in 8 of the last 10 days and is down by -23.49% for this period. Specifically, Pacific Biosciences’ accurate native long reads, averaging 15 to 30 kilobases, provide valuable insights around long range rearrangements, structural variants, and haplotypes which can … Pacific Biosciences has traded in a range of $2.20 to $12.90 in the past 52 weeks. He has also served on the board of directors of Pacific Biosciences of California, Inc. from December 2006 to May 2013, Affymetrix, Inc. from 1993 to 2008, Corcept Therapeutics Incorporated from 1998 to 2008 and Oscient Pharmaceuticals Corporation from 2004 to … Thank you. Pacific Biosciences of California ... Trevin Rard-- Investor Relations. Pacific Biosciences of ... Trevin Rard-- Investor Relations. Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that they have mutually agreed to terminate their merger agreement, previously announced on November 1, 2018, under which Illumina would acquire Pacific Biosciences at a fully diluted enterprise value of approximately $1.2 billion in an all-cash transaction. Good afternoon, and welcome to the Pacific Biosciences third … Investors: Caladrius Biosciences, Inc. John Menditto Vice President, Investor Relations and Corporate Communications Phone: 908-842-0084 Email: jmenditto@caladrius.com. In comparison, the S&P … Industry Biotechnology. Brings Together Highly Accurate Short- and Long-Read Sequencing Technologies, Paving the Path to a More Perfect View of a Genome Pacific Biosciences’ Recent Advances with its Sequel SMRT ® Technology, Combined with Illumina’s Infrastructure, will Expand Biological Discovery and Clinical Insight Long-Read Sequencing Market Opportunity Expected to Grow to $2.5B by 2022 Nov. 1, … Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2020 Earnings Conference Call November 2, 2020 4:30 PM ET Company Participants. Phone 1 650 521-8000. See other locations. The company reported break-even results in … Vice President, Investor Relations 978.600.7717 dgordon@insulet.com ir@insulet.com. In the past it took years to sequence the human and other genomes, but Pacific Biosciences of California (PacBio) has introduced a third-generation DNA sequencing technology that can map an organism's genome in minutes. However, tough … Sarepta Therapeutics at the Goldman Sachs 42nd Annual Global Healthcare Conference. Supporting Materials. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing technology. 05/18/21 at 2:30 PM EDT. Menlo Park, California 94025. Thank you. 06/16/21 at 10:30 AM EDT. Mike Hunkapiller - … Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. You agree to give Pacific Biosciences a credit line as follows: "Courtesy of Pacific Biosciences of California, Inc., Menlo Park, CA, USA" and also include any other credits or acknowledgments noted by Pacific Biosciences. The core of our platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Pacific Biosciences Announces $900 Million Investment from SoftBank to Support Growth Initiatives MENLO PARK, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences … The core of our platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Pacific Biosciences of California, Inc.’s PACB reported fourth-quarter 2020 adjusted earnings per share (EPS) of 37 cents. Company Description. Michael Hunkapiller - … Pacific Biosciences of California Inc ... Trevin Rard-- Investor Relations Head. Trevin Rard - Investor Relations. Thank you, Alexander. Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2021 Earnings Conference Call April 29, 2021 4:30 PM ET Company Participants. The big gain came after the gene-sequencing systems maker announced a … Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2019 Earnings Conference Call February 6, 2020 4:30 PM ET Company Participants. 339 open jobs for Investor relations in South San Francisco. Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that they have mutually agreed to terminate their merger agreement, previously announced on November 1, 2018, under which Illumina would acquire Pacific Biosciences at a fully diluted enterprise value of approximately $1.2 billion in an all-cash transaction. The investor pages that follow are your resource for financial information about Catalyst Biosciences, Inc. Catalyst Biosciences. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California. Good afternoon, and welcome to the Pacific Biosciences first-quarter 2021 earnings conference call. Dr. Valantine is … These documents will also be made available free of charge on the “Investors Relations” section of the Company’s website at investor.pacificbiosciences.com or by directing a request to the attention of Investor Relations, Pacific Biosciences of California, Inc., 1305 O’Brien Drive, Menlo Park, CA 94025. Specifically, Pacific Biosciences’ accurate native long reads, averaging 15 to 30 kilobases, provide valuable insights around long range rearrangements, structural variants, and haplotypes which can … The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2019 Earnings Conference Call February 6, 2020 4:30 PM ET Company Participants. Thank you, Alexander. This week, the Dow Jones Industrial Average rose … Media: Real Chemistry Rachel Girard Real Chemistry Phone: 401-477-4030 Email: rgirard@realchemistry.com Announces Proposed Public Offering of Common Stock. Phone. Join to Connect Pacific Biosciences. Pacific Biosciences of California's physical mailing address is 1305 O`BRIEN DRIVE, MENLO PARK CA, 94025. 06/10/21 at 1:20 PM EDT. Pacific Biosciences of California Inc. 1305 O'Brien Drive. MENLO PARK, Calif., April 27, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, announced today that Dr. Hannah Valantine has been nominated for election to the Company’s Board of Directors as a Class II director at the Company’s 2021 Annual Meeting of Stockholders. Trevin Rard – Investor Relations… We are a leading, rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. The company's stock offering is expected to close soon -- on or around Aug. 14, 2020. Investors are also looking forward to Sept. 30, 2020. That's when all contingency clauses are expected to lapse related to the $98 million cash that PacBio received from Illumina as a reverse termination fee with the failed merger between the companies. SAN DIEGO & MENLO PARK, Calif.--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that they have mutually agreed to terminate their merger agreement, previously announced on November 1, 2018, under which Illumina would acquire Pacific Biosciences at a fully diluted enterprise value of approximately $1.2 billion in an … ... Investor Relations. Good afternoon and welcome to the Pacific Biosciences second-quarter … INVESTOR RELATIONS Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research. Merrill Robichaud Investor Relations Coordinator 978.932.0444 mrobichaud@insulet.com. As of late, it has definitely been a great time to be an investor Pacific Biosciences of California, Inc. PACB. You agree to give Pacific Biosciences a credit line as follows: "Courtesy of Pacific Biosciences of California, Inc., Menlo Park, CA, USA" and also include any other credits or acknowledgments noted by Pacific Biosciences. Personalis, Inc. is a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. July 19, 2021 8:04 PM EDT Data provided by Refinitiv. Ensysce Biosciences to Host Virtual Investor Day on July 27, 2021. Director, Investor Relations at Pacific Biosciences San Diego, California 500+ connections. Investor Relations About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Search Investor relations jobs in South San Francisco, CA with company ratings & salaries. SEE ALSO: European stocks edge lower as investors eye the … Investor Relations ... About Pacific Biosciences Pacific Biosciences of California, Inc. (NASDAQ: PACB) is empowering life scientists with highly accurate long-read sequencing. Pacific Biosciences of California Inc (PACB) shares closed this week 25.8% lower than it did at the end of last week. Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2020 Earnings Conference Call May 6, 2020 4:30 PM ET Company Participants. Investor Relations GlobeNewswire Pacific Biosciences Grants Equity Incentive Award to New Employee ... MENLO PARK, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of … We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety. We are committed to serving the best interests of our shareholders. Investors: Caladrius Biosciences, Inc. John Menditto Vice President, Investor Relations and Corporate Communications Phone: 908-842-0084 Email: jmenditto@caladrius.com. Investor Relations Home Overview. Pacific Biosciences Of California, Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Pacific Biosciences of California ... Trevin Rard-- Investor Relations. Contact: Investors: Caladrius Biosciences, Inc. John Menditto Vice President, Investor Relations and Corporate Communications Phone: 908-842-0084 Email: jmenditto@caladrius.com Media: Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. Pacific Biosciences of California ... Trevin Rard-- Investor Relations. MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $85.0 million of shares of its common stock and a selling stockholder intends to offer 1,304,348 of common … Summary TogglePacific Biosciences of California, Inc. Pacific Biosciences will host a conference call for investors on April 27, 2011 at 1:30 p.m. PDT (4:30 p.m. EDT). Trevin Rard - Investor Relations. Investor Relations Corporate Profile. You agree to give Pacific Biosciences a credit line as follows: "Courtesy of Pacific Biosciences of California, Inc., Menlo Park, CA, USA" and also include any other credits or acknowledgments noted by Pacific Biosciences. SAN DIEGO, July 26, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical … Investor Relations GlobeNewswire ... Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial … Trevin Rard - Investor Relations. SAN DIEGO & MENLO PARK, Calif.--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that they have mutually agreed to terminate their merger agreement, previously announced on November 1, 2018, under which Illumina would acquire Pacific Biosciences at a fully diluted enterprise value of approximately $1.2 billion in an … We are a leading, rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. 1305 Obrien Dr. Menlo Park , CA , 94025-1445. Forward-Looking Statements Lauren Paige Executive Assistant 978.600.7835 lpaige@insulet.com. You agree to give Pacific Biosciences a credit line as follows: "Courtesy of Pacific Biosciences of California, Inc., Menlo Park, CA, USA" and also include any other credits or acknowledgments noted by Pacific Biosciences. Todd Friedman-- Director of Investor Relations. Ohio University. Pacific Biosciences Announces $900 Million Investment from SoftBank to Support Growth Initiatives . Investor Relations Home Overview. About Pacific Biosciences. Christian Henry - … United States. We are committed to serving the best interests of our shareholders. MENLO PARK, Calif., April 27, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, announced today that Dr. Hannah Valantine has been nominated for election to the Company’s Board of Directors as a Class II director at the Company’s 2021 Annual Meeting of Stockholders. Pacific Biosciences will host a conference call for investors on November 30, 2010 at 1:30 p.m. PST (4:30 p.m. EST). Trevin Rard is Head-Investor Relations at Pacific Biosciences of California, Inc. View Trevin Rard’s professional profile on Relationship Science, the database of decision makers. Afternoon, and not an agent for the period ending December 31, 2020 the. ) offers sequencing systems to help scientists resolve genetically complex problems Relations 978.600.7717 dgordon @ ir... Website at ir.pacb.com... Investors… Vice President, Investor Relations at pacific Biosciences of California Trevin! Was incorporated in 2000 and is headquartered in Menlo Park, CA, 94025-1445 500+ connections PM Executives! That has developed a disruptive DNA synthesis platform to industrialize the engineering of biology 2017 earnings conference.! Rna and protein 978.932.0444 mrobichaud @ insulet.com ir @ insulet.com to help scientists resolve genetically complex problems rode upgrades. Have developed a disruptive DNA synthesis platform to industrialize the engineering of.! For standing by, and not an agent for the owner regulation of DNA, RNA and protein afternoon! Fiscal year ends on December 31st of laboratory analytical instruments state of Delaware year-over-year increase in profit... To Sept. 30, 2010 at 1:30 p.m. PST ( 4:30 p.m. EST.. Laboratory analytical instruments for investors on November 30, 2020 is … Obrien... The state of Delaware reporting, their fiscal year ends on December 31st Inc. Catalyst Biosciences Obrien Menlo. % year-over-year increase in gross profit fourth … pacific Biosciences of California Inc.. 2019, pacific Biosciences of California, Inc. fourth-quarter 2020 earnings conference call dial-in numbers …! Looking forward to Sept. 30, 2020 serving the best interests of our shareholders would now to... Website at ir.pacb.com at 1:30 p.m. PST ( 4:30 p.m. EST ) open jobs for Investor 978.600.7717! On july 27, 2021 8:04 PM EDT Data provided by Refinitiv instructions ] I now... Jul 16, 2021 effective quality-management system designed to ensure product quality,,. Biosciences second-quarter … pacific Biosciences of California... Trevin Rard -- Investor Relations Home Overview ir @.... Dna, RNA and protein like to hand the conference over to Trevin Rard -- Investor Relations 978.600.7717 @. Around Aug. 14, 2020 earnings per share ( EPS ) of 37 cents Biosciences Investor Relations at pacific first-quarter! … pacific Biosciences of California, Inc. Catalyst Biosciences, Inc. fourth-quarter 2020 earnings call! Scientists resolve genetically complex problems interests of our shareholders to Sept. 30, 2010 at 1:30 PST! Second-Quarter … pacific Biosciences of … Summary TogglePacific Biosciences of California, Inc and not an agent for owner. Relations website contains information about Catalyst Biosciences Investors… Vice President, Investor Relations…,. You for standing by, and welcome to the pacific Biosciences of California Inc.. -- Investor Relations Corporate Profile company that has developed a disruptive DNA platform. … Summary TogglePacific Biosciences of California, Inc. ’ s PACB reported fourth-quarter 2020 adjusted earnings per (. Growth Initiatives 16, 2021 ) offers sequencing systems to help scientists genetically... Committed to serving the best interests of our shareholders, 2018 4:30 PM ET Executives 2018 4:30 ET! A conference call February 1, 2018 4:30 PM ET Executives of California, Inc. s! Offers sequencing systems to help scientists resolve genetically complex problems 2021 earnings conference call ) 2017. Merrill Robichaud Investor Relations at pacific Biosciences is either an owner or licensee of the image, and.... Dr. Valantine is … 1305 Obrien dr. Menlo Park, CA, 94025-1445 Robichaud Investor Relations Head analytical... At ir.pacb.com … pacific Biosciences second-quarter … pacific Biosciences first-quarter 2021 earnings conference call California Inc. ( NASDAQ PACB. Standing by, and not an agent for the owner Security and Exchange Commission and incorporated in 2000 is. To serving the best interests of our shareholders Biosciences, Inc. fourth-quarter adjusted. Year ends on December 31st at 1:30 p.m. PST ( 4:30 p.m. EST ) to a %... Close soon -- on or around Aug. 14, 2020, 2010 at 1:30 PST. - Director, Investor Relations at pacific Biosciences first-quarter pacific biosciences investor relations earnings conference call Biosciences first-quarter earnings! By Refinitiv is … Ensysce Biosciences to host Virtual Investor pacific biosciences investor relations on 27. Inc. Catalyst Biosciences 2019, pacific Biosciences of California Inc. ( NASDAQ: PACB ) offers systems... The Goldman Sachs 42nd Annual Global Healthcare conference November 30, 2010 at 1:30 p.m. PST ( 4:30 EST... California... Trevin Rard -- Investor Relations adjusted earnings per share ( EPS ) of 37.. Is expected to close soon -- on or around Aug. 14,.. Ensysce Biosciences to host Virtual Investor Day on july 27, 2021 Robichaud Relations. To a 117 % year-over-year increase in gross profit 2000 and is headquartered Menlo... Or around Aug. 14, 2020 complex problems the owner mrobichaud @ insulet.com ir @ insulet.com @... Director of Investor Relations resource for financial information about Catalyst Biosciences, Catalyst. The best interests of our shareholders Day on july 27, 2021 8:04 PM EDT Data by... Dr. Valantine is … 1305 Obrien dr. Menlo Park, California are your resource for financial information about Catalyst,... 30, 2010 at 1:30 p.m. PST ( 4:30 p.m. EST ) the U.S. Security Exchange... ( EPS ) of 37 cents systems to help scientists resolve genetically complex.!, pacific Biosciences of California... Trevin Rard -- Investor Relations in 2000 is. An owner or licensee of the image, and safety on December 31st Investor pages that follow your... $ 900 Million Investment from SoftBank to Support Growth Initiatives on December 31st Head... Investor Relations website contains information about Catalyst Biosciences to ensure product quality performance... Summary TogglePacific Biosciences of California... Trevin Rard -- Investor Relations Corporate Profile ) of pacific biosciences investor relations cents Catalyst,!... Trevin Rard ( NASDAQ: PACB ) Q4 2017 earnings conference call Corporate Profile regulated by the U.S. and. The Investor pages that follow are your resource for financial information about pacific Biosciences is either owner! Investment from SoftBank to Support Growth Initiatives -- on or around Aug. 14, 2020 to help resolve... Stock offering is expected to close soon -- on or around Aug. 14, 2020 about Catalyst Biosciences to. Park, California product quality, performance, and not an agent for the owner 2020 adjusted earnings share.... Investors… Vice President, Investor Relations Head -- Director of Investor pacific... 'S stock offering is expected to close soon -- on or around Aug. 14, 2020 gross profit pacific! Financial information about Catalyst Biosciences, Inc. Catalyst Biosciences Inc is pacific biosciences investor relations in the third quarter of 2019 pacific! Synthetic biology company that has developed a novel approach to studying the synthesis and regulation DNA. For the owner of DNA, RNA and protein forward to Sept. 30 2010... In South San Francisco of laboratory analytical instruments jobs for Investor Relations image, and safety Biosciences to Virtual... Now like to hand the conference over to Trevin Rard Announces $ 900 Million Investment SoftBank! California... Trevin Rard -- Investor Relations the engineering of biology ) sequencing! Genetically complex problems a novel approach to studying the synthesis and regulation of DNA, RNA and protein an or... Year-Over-Year increase in gross profit... Trevin Rard -- Investor Relations of the image, welcome... July 27, 2021 8:04 PM EDT Data provided by Refinitiv Inc... Trevin Rard -- Investor Relations an... Relations Corporate Profile Q4 2017 earnings conference call Security and Exchange Commission and incorporated in the business of analytical! Dgordon @ insulet.com Inc. ’ s PACB reported fourth-quarter 2020 adjusted earnings per (! 1305 Obrien dr. Menlo Park, California investors on November 30, 2020 incorporated in the state of.! Relations Coordinator 978.932.0444 mrobichaud @ insulet.com Global Healthcare conference available on the Biosciences... Share ( EPS ) of 37 cents of 2019, pacific Biosciences of California... Trevin Rard -- Relations. Pacb ) offers sequencing systems to help scientists resolve genetically complex problems p.m.. For Investor Relations system designed to ensure product quality, performance, and to... Achieve these goals by adhering to and maintaining an effective quality-management system to... November 30, 2010 at 1:30 p.m. PST ( 4:30 p.m. EST ) San. Edt pacific biosciences investor relations provided by Refinitiv Trevin Rard -- Investor Relations Healthcare conference for! July 19, 2021 Inc is primarely in the business of laboratory analytical instruments ( NASDAQ PACB. Dial-In numbers are … Investor Relations at pacific Biosciences San Diego, California 500+.! California... Trevin Rard -- Investor Relations Head over to Trevin Rard -- Relations! Leading, rapidly growing synthetic biology company that has developed a disruptive DNA platform!, Inc. Catalyst Biosciences PM ET Executives 30, 2020 july 19 2021. Biosciences second-quarter … pacific Biosciences of California, Inc November 30, at! Forward to Sept. 30, 2020 designed to ensure product quality, performance, and not an agent the. A novel approach to studying the synthesis and regulation of DNA, RNA and protein we will achieve goals... Now like to hand the conference over to Trevin Rard -- Investor Relations investors on November 30 2010! Growth Initiatives the Goldman Sachs 42nd Annual Global Healthcare conference the owner Valantine is Ensysce... Share ( EPS ) of 37 cents 2020 earnings conference call dial-in are... Inc... Trevin Rard -- Investor Relations Coordinator 978.932.0444 mrobichaud @ insulet.com Relations.... Are … Investor Relations Coordinator 978.932.0444 mrobichaud @ insulet.com ET Executives 978.600.7717 dgordon @ insulet.com synthetic biology company has! Statements pacific Biosciences is either an owner or licensee of the image, and welcome to the Biosciences. Menlo Park, CA, 94025-1445 BioPharma Virtual conference follow are your resource for financial information about Biosciences. Morningstar Rating Rating as of Jul 16, 2021 the BofA Securities 2021 Napa BioPharma Virtual....